NG
VRTX icon

Norden Group’s Vertex Pharmaceuticals VRTX Stock Holding History

Norden Group’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.68M Buy
3,757
+389
+12% +$181K 0.16% 119
2025
Q4 		$1.53M Buy
3,368
+1,016
+43% +$438K 0.15% 121
2025
Q3 		$921K Sell
2,352
-223
-9% -$93.2K 0.09% 203
2025
Q2 		$1.15M Buy
2,575
+787
+44% +$363K 0.12% 161
2025
Q1 		$867K Sell
1,788
-60
-3% -$28K 0.1% 197
2024
Q4 		$744K Buy
1,848
+183
+11% +$84.8K 0.08% 251
2024
Q3 		$774K Buy
1,665
+286
+21% +$137K 0.09% 239
2024
Q2 		$646K Buy
1,379
+387
+39% +$168K 0.13% 171
2024
Q1 		$415K Buy
992
+377
+61% +$159K 0.08% 269
2023
Q4 		$250K Buy
+615
New +$227K 0.04% 232

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Norden Group's VRTX Position: Q1 2026 in Review

Norden Group increased its Vertex Pharmaceuticals (VRTX) stake by 12% in Q1 2026, buying an estimated $181K and bringing the position to 3,757 shares worth $1.68M. The position accounts for 0.16% of the portfolio, ranked #119.

Norden Group first reported a position in VRTX in Q4 2023 and has held it in 10 quarters since. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • Norden Group held 3,757 shares of Vertex Pharmaceuticals worth $1.68M as of Q1 2026.
  • Norden Group bought 389 Vertex Pharmaceuticals shares in Q1 2026, an estimated $181K.
  • Vertex Pharmaceuticals made up 0.16% of Norden Group's portfolio in Q1 2026, its #119 holding.
  • Norden Group first reported a position in Vertex Pharmaceuticals in Q4 2023 and has held it in 10 quarters since.
  • 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Norden Group's 13F filing for Q1 2026, filed 15 Apr 2026.